Curaleaf has acquired the Polish company Can4Med. "This acquisition represents a significant step forward for Curaleaf International. Poland's medical cannabis market is expanding rapidly, and our partnership with Can4Med allows us to better serve patients while driving growth across Europe," said Matt Darin, CEO of Curaleaf.
"We are thrilled that Can4med, a pioneering force in Poland's cannabis market, has joined forces with Curaleaf. This acquisition marks a significant milestone in our journey, ensuring an unparalleled supply chain that positions us to meet and exceed the demands of the entire Polish market. Partnering with Curaleaf not only reinforces our commitment to quality and accessibility but also signifies a new era of growth and possibilities for both companies and our customers," said Maximilian Weinberg, founder of Can4med.
For more information:
Curaleaf
[email protected]
curaleaf.com